Neutrophil-derived relaxing factor relaxes vascular smooth muscle through a cGMP-mediated mechanism
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 46 (21) , 1531-1538
- https://doi.org/10.1016/0024-3205(90)90426-r
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Endothelium‐derived nitric oxide: actions and propertiesThe FASEB Journal, 1989
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclaseEuropean Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro.Journal of Clinical Investigation, 1987
- Modulation of Vascular Smooth Muscle Contraction by the EndotheliumAnnual Review of Physiology, 1986
- ACTIVATION OF PURIFIED SOLUBLE GUANYLATE-CYCLASE BY ENDOTHELIUM-DERIVED RELAXING FACTOR FROM INTRAPULMONARY ARTERY AND VEIN - STIMULATION BY ACETYLCHOLINE, BRADYKININ AND ARACHIDONIC-ACID1986
- Leukocytes and Ischemia-Induced Myocardial InjuryAnnual Review of Pharmacology and Toxicology, 1986
- Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries.Circulation Research, 1986
- Role of endothelium in responses of vascular smooth muscle.Circulation Research, 1983